Skip to content

Wyler Subdural Strip Electrode

by Ad-Tech Medical Instrument Corp.

510(k) K850342

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SN Traditional NumberK850342 Date30 Jul 1985DecidedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
GYC
FDA applicant
Ad-Tech Medical Instrument Corp
Device class
Class II
Regulation
21 CFR Part 882.1310
Advisory committee
Neurology
FDA decision
SN

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Wyler Subdural Strip Electrode is a Cortical Electrode designed for intracranial electroencephalography (iEEG) monitoring. It is intended for recording electrical activity from the brain’s subdural space, aiding in the diagnosis and management of epilepsy and other neurological conditions by providing continuous, high-resolution data on brain function.

This device is supplied sterile and intended for single-use, featuring platinum or stainless steel construction with contacts spaced 10mm apart on an 8mm-wide strip. It is regulated under FDA 510(k) clearance (K850342) and falls under Class II medical device classification (GYC). Usage is restricted to clinical settings, such as operating rooms or intensive care units, where intracranial monitoring is required.

From the manufacturer

Ad-Tech Medical Instrument Corporation The World's Leader As the world leader, Ad-Tech's electrode devices are used in surgical cases for long-term EEG monitoring*, brain mapping, SEEG, and brain stimulation of persons with intractable epilepsy and other brain diseases/disorders. *Long Term Monitoring: Device use is indicated for up to 29 days.

Source: adtechmedical.com

Other devices from Ad-Tech Medical Instrument Corp.

See all devices from Ad-Tech Medical Instrument Corp. →